ZYMtronix, Inc. is a biotechnology startup that services enzyme and pharmaceutical manufacturers. ZYMtronix immobilizes and optimizes biocatalysts for continuous manufacturing using green chemistry principles to lower the costs and increase the yields of drug manufacturing. Their breakthrough enzyme immobilization platform improves the activity, stability, and reusability of any enzyme. Magnetic nanoparticles allow for greater control over biocatalysts without loss in activity. It is the mission of ZYMtronix to make biocatalysts work more efficiently in the agriculture, fine chemical manufacturing, and safety testing industries.
The company's foundational technology was developed at, and is licensed from, Cornell University.